Close
4

Athena Athena

X

Find Ramipril manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
573
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • CAPSULE;ORAL - 1.25MG
  • CAPSULE;ORAL - 10MG
  • CAPSULE;ORAL - 2.5MG
  • CAPSULE;ORAL - 5MG

Looking for 87333-19-5 / Ramipril API manufacturers, exporters & distributors?

Ramipril manufacturers, exporters & distributors 1

66

PharmaCompass offers a list of Ramipril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ramipril manufacturer or Ramipril supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ramipril manufacturer or Ramipril supplier.

PharmaCompass also assists you with knowing the Ramipril API Price utilized in the formulation of products. Ramipril API Price is not always fixed or binding as the Ramipril Price is obtained through a variety of data sources. The Ramipril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ramipril

Synonyms

87333-19-5, Tritace, Altace, Ramace, Triatec, Delix

Cas Number

87333-19-5

Unique Ingredient Identifier (UNII)

L35JN3I7SJ

About Ramipril

A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.

MolPort-001-736-571 Manufacturers

A MolPort-001-736-571 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-001-736-571, including repackagers and relabelers. The FDA regulates MolPort-001-736-571 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-001-736-571 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MolPort-001-736-571 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

MolPort-001-736-571 Suppliers

A MolPort-001-736-571 supplier is an individual or a company that provides MolPort-001-736-571 active pharmaceutical ingredient (API) or MolPort-001-736-571 finished formulations upon request. The MolPort-001-736-571 suppliers may include MolPort-001-736-571 API manufacturers, exporters, distributors and traders.

click here to find a list of MolPort-001-736-571 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

MolPort-001-736-571 USDMF

A MolPort-001-736-571 DMF (Drug Master File) is a document detailing the whole manufacturing process of MolPort-001-736-571 active pharmaceutical ingredient (API) in detail. Different forms of MolPort-001-736-571 DMFs exist exist since differing nations have different regulations, such as MolPort-001-736-571 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A MolPort-001-736-571 DMF submitted to regulatory agencies in the US is known as a USDMF. MolPort-001-736-571 USDMF includes data on MolPort-001-736-571's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MolPort-001-736-571 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of MolPort-001-736-571 suppliers with USDMF on PharmaCompass.

MolPort-001-736-571 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a MolPort-001-736-571 Drug Master File in Korea (MolPort-001-736-571 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of MolPort-001-736-571. The MFDS reviews the MolPort-001-736-571 KDMF as part of the drug registration process and uses the information provided in the MolPort-001-736-571 KDMF to evaluate the safety and efficacy of the drug.

After submitting a MolPort-001-736-571 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their MolPort-001-736-571 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of MolPort-001-736-571 suppliers with KDMF on PharmaCompass.

MolPort-001-736-571 CEP

A MolPort-001-736-571 CEP of the European Pharmacopoeia monograph is often referred to as a MolPort-001-736-571 Certificate of Suitability (COS). The purpose of a MolPort-001-736-571 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MolPort-001-736-571 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MolPort-001-736-571 to their clients by showing that a MolPort-001-736-571 CEP has been issued for it. The manufacturer submits a MolPort-001-736-571 CEP (COS) as part of the market authorization procedure, and it takes on the role of a MolPort-001-736-571 CEP holder for the record. Additionally, the data presented in the MolPort-001-736-571 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MolPort-001-736-571 DMF.

A MolPort-001-736-571 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MolPort-001-736-571 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of MolPort-001-736-571 suppliers with CEP (COS) on PharmaCompass.

MolPort-001-736-571 WC

A MolPort-001-736-571 written confirmation (MolPort-001-736-571 WC) is an official document issued by a regulatory agency to a MolPort-001-736-571 manufacturer, verifying that the manufacturing facility of a MolPort-001-736-571 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting MolPort-001-736-571 APIs or MolPort-001-736-571 finished pharmaceutical products to another nation, regulatory agencies frequently require a MolPort-001-736-571 WC (written confirmation) as part of the regulatory process.

click here to find a list of MolPort-001-736-571 suppliers with Written Confirmation (WC) on PharmaCompass.

MolPort-001-736-571 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MolPort-001-736-571 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for MolPort-001-736-571 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture MolPort-001-736-571 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain MolPort-001-736-571 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MolPort-001-736-571 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of MolPort-001-736-571 suppliers with NDC on PharmaCompass.

MolPort-001-736-571 GMP

MolPort-001-736-571 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of MolPort-001-736-571 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MolPort-001-736-571 GMP manufacturer or MolPort-001-736-571 GMP API supplier for your needs.

MolPort-001-736-571 CoA

A MolPort-001-736-571 CoA (Certificate of Analysis) is a formal document that attests to MolPort-001-736-571's compliance with MolPort-001-736-571 specifications and serves as a tool for batch-level quality control.

MolPort-001-736-571 CoA mostly includes findings from lab analyses of a specific batch. For each MolPort-001-736-571 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

MolPort-001-736-571 may be tested according to a variety of international standards, such as European Pharmacopoeia (MolPort-001-736-571 EP), MolPort-001-736-571 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MolPort-001-736-571 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY